Optimal (≤1 cm) but visible residual disease: is extensive debulking warranted?
Barlin JN, Long KC, Tanner EJ, Gardner GJ, Leitao MM Jr, Levine DA, Sonoda Y, Abu-Rustum NR, Barakat RR, Chi DS.
Barlin JN, et al. Among authors: tanner ej.
Gynecol Oncol. 2013 Aug;130(2):284-8. doi: 10.1016/j.ygyno.2013.05.006. Epub 2013 May 11.
Gynecol Oncol. 2013.
PMID: 23672929